CALIFORNIA NANOTECHNOLOGIES (CNO.CA) Stock Fundamental Analysis
Canada - TSX-V:CNO - CA1304921010 - Common Stock
0.395 CAD
+0.02 (+3.95%)
Overall CNO gets a fundamental rating of 5 out of 10. We evaluated CNO against 24 industry peers in the Machinery industry. CNO has only an average score on both its financial health and profitability. CNO is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CNO has reported negative net income.
In the past year CNO had a positive cash flow from operations.
In multiple years CNO reported negative net income over the last 5 years.
Each year in the past 5 years CNO had a positive operating cash flow.
1.2 Ratios
CNO has a worse Return On Assets (-27.36%) than 70.83% of its industry peers.
CNO has a worse Return On Equity (-59.99%) than 70.83% of its industry peers.
CNO has a Return On Invested Capital of 7.76%. This is in the better half of the industry: CNO outperforms 70.83% of its industry peers.
CNO had an Average Return On Invested Capital over the past 3 years of 30.56%. This is significantly above the industry average of 7.34%.
The 3 year average ROIC (30.56%) for CNO is well above the current ROIC(7.76%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.36% | ||
| ROE | -59.99% | ||
| ROIC | 7.76% |
ROA(3y)7%
ROA(5y)3.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)30.56%
ROIC(5y)N/A
1.3 Margins
The Operating Margin of CNO (7.11%) is better than 75.00% of its industry peers.
CNO's Operating Margin has improved in the last couple of years.
The Gross Margin of CNO (74.15%) is better than 100.00% of its industry peers.
CNO's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.11% | ||
| PM (TTM) | N/A | ||
| GM | 74.15% |
OM growth 3Y4.57%
OM growth 5Y69.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y3.23%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CNO is creating value.
The number of shares outstanding for CNO has been increased compared to 1 year ago.
Compared to 5 years ago, CNO has more shares outstanding
Compared to 1 year ago, CNO has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.01 indicates that CNO is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.01, CNO is in the better half of the industry, outperforming 70.83% of the companies in the same industry.
CNO has a debt to FCF ratio of 1.33. This is a very positive value and a sign of high solvency as it would only need 1.33 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.33, CNO belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
CNO has a Debt/Equity ratio of 0.58. This is a neutral value indicating CNO is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.58, CNO perfoms like the industry average, outperforming 54.17% of the companies in the same industry.
Even though the debt/equity ratio score it not favorable for CNO, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | 1.33 | ||
| Altman-Z | 3.01 |
ROIC/WACC0.83
WACC9.37%
2.3 Liquidity
A Current Ratio of 0.92 indicates that CNO may have some problems paying its short term obligations.
CNO's Current ratio of 0.92 is on the low side compared to the rest of the industry. CNO is outperformed by 83.33% of its industry peers.
A Quick Ratio of 0.92 indicates that CNO may have some problems paying its short term obligations.
With a Quick ratio value of 0.92, CNO is not doing good in the industry: 70.83% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
CNO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -209.47%.
CNO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.45%.
The Revenue has been growing by 49.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-209.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-165.75%
Revenue 1Y (TTM)13.45%
Revenue growth 3Y79.21%
Revenue growth 5Y49.59%
Sales Q2Q%-59.02%
3.2 Future
Based on estimates for the next years, CNO will show a very strong growth in Earnings Per Share. The EPS will grow by 102.34% on average per year.
Based on estimates for the next years, CNO will show a very negative growth in Revenue. The Revenue will decrease by -11.18% on average per year.
EPS Next Y100%
EPS Next 2Y102.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-42.3%
Revenue Next 2Y-11.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CNO. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 27.29 indicates a quite expensive valuation of CNO.
Based on the Price/Forward Earnings ratio, CNO is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
CNO is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.94, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 27.29 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNO indicates a somewhat cheap valuation: CNO is cheaper than 66.67% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNO indicates a rather cheap valuation: CNO is cheaper than 95.83% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.62 | ||
| EV/EBITDA | 13.99 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CNO may justify a higher PE ratio.
CNO's earnings are expected to grow with 102.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y102.34%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CNO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:CNO (10/17/2025, 7:00:00 PM)
0.395
+0.02 (+3.95%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners14.5%
Ins Owner ChangeN/A
Market Cap18.98M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 27.29 | ||
| P/S | 2.6 | ||
| P/FCF | 11.62 | ||
| P/OCF | 4.12 | ||
| P/B | 6.22 | ||
| P/tB | 6.23 | ||
| EV/EBITDA | 13.99 |
EPS(TTM)-0.04
EYN/A
EPS(NY)0.01
Fwd EY3.66%
FCF(TTM)0.03
FCFY8.61%
OCF(TTM)0.1
OCFY24.27%
SpS0.15
BVpS0.06
TBVpS0.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -27.36% | ||
| ROE | -59.99% | ||
| ROCE | 10.78% | ||
| ROIC | 7.76% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.99% | ||
| OM | 7.11% | ||
| PM (TTM) | N/A | ||
| GM | 74.15% | ||
| FCFM | 22.4% |
ROA(3y)7%
ROA(5y)3.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)30.56%
ROIC(5y)N/A
ROICexc(3y)60.79%
ROICexc(5y)N/A
ROICexgc(3y)61.38%
ROICexgc(5y)N/A
ROCE(3y)19.86%
ROCE(5y)N/A
ROICexcg growth 3Y-3.97%
ROICexcg growth 5Y27%
ROICexc growth 3Y-3.63%
ROICexc growth 5Y32.06%
OM growth 3Y4.57%
OM growth 5Y69.99%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y3.23%
F-Score5
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.58 | ||
| Debt/FCF | 1.33 | ||
| Debt/EBITDA | 1.25 | ||
| Cap/Depr | 332.29% | ||
| Cap/Sales | 40.75% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 325.91% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 3.01 |
F-Score5
WACC9.37%
ROIC/WACC0.83
Cap/Depr(3y)145.85%
Cap/Depr(5y)N/A
Cap/Sales(3y)13.6%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-209.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-165.75%
EPS Next Y100%
EPS Next 2Y102.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.45%
Revenue growth 3Y79.21%
Revenue growth 5Y49.59%
Sales Q2Q%-59.02%
Revenue Next Year-42.3%
Revenue Next 2Y-11.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-68.17%
EBIT growth 3Y87.4%
EBIT growth 5Y154.28%
EBIT Next Year-68.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y279.82%
FCF growth 3Y80.29%
FCF growth 5Y42.36%
OCF growth 1Y787.9%
OCF growth 3Y173%
OCF growth 5Y84.63%